View in EDS HTML Full Text PDF Full Text

Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma.

Saved in:
Bibliographic Details
Title: Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma.
Authors: Rimassa L; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy.; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy., Kelley RK; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA., Meyer T; Royal Free Hospital and UCL Cancer Institute, London, United Kingdom., Ryoo BY; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Merle P; Groupement Hospitalier Lyon Nord, Lyon, France., Park JW; National Cancer Center, Goyang, Republic of Korea., Blanc JF; Hôpital Haut-Lévêque, CHU Bordeaux, Bordeaux, France., Lim HY; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Tran A; Université Côte d'Azur, Nice, France.; CHU de Nice, Digestive Center, Nice, France.; INSERM, U1065, C3M, Team 8, Nice, France., Chan YW; Fios Genomics Ltd, Edinburgh, United Kingdom., McAdam P; Fios Genomics Ltd, Edinburgh, United Kingdom., Wang E; Exelixis, Inc., Alameda, California, USA., Cheng AL; National Taiwan University College of Medicine, Taipei, Taiwan., El-Khoueiry AB; USC Norris Comprehensive Cancer Center, Los Angeles, California, USA., Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Weill Medical College at Cornell University, New York, New York, USA.
Source: Liver cancer [Liver Cancer] 2021 Dec 03; Vol. 11 (1), pp. 38-47. Date of Electronic Publication: 2021 Dec 03 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101597993 Publication Model: eCollection Cited Medium: Print ISSN: 2235-1795 (Print) Linking ISSN: 16645553 NLM ISO Abbreviation: Liver Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35222506
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rimassa+L%22">Rimassa L</searchLink>; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy.; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy.<br /><searchLink fieldCode="AU" term="%22Kelley+RK%22">Kelley RK</searchLink>; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Meyer+T%22">Meyer T</searchLink>; Royal Free Hospital and UCL Cancer Institute, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ryoo+BY%22">Ryoo BY</searchLink>; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Merle+P%22">Merle P</searchLink>; Groupement Hospitalier Lyon Nord, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Park+JW%22">Park JW</searchLink>; National Cancer Center, Goyang, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Blanc+JF%22">Blanc JF</searchLink>; Hôpital Haut-Lévêque, CHU Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Lim+HY%22">Lim HY</searchLink>; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Tran+A%22">Tran A</searchLink>; Université Côte d'Azur, Nice, France.; CHU de Nice, Digestive Center, Nice, France.; INSERM, U1065, C3M, Team 8, Nice, France.<br /><searchLink fieldCode="AU" term="%22Chan+YW%22">Chan YW</searchLink>; Fios Genomics Ltd, Edinburgh, United Kingdom.<br /><searchLink fieldCode="AU" term="%22McAdam+P%22">McAdam P</searchLink>; Fios Genomics Ltd, Edinburgh, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wang+E%22">Wang E</searchLink>; Exelixis, Inc., Alameda, California, USA.<br /><searchLink fieldCode="AU" term="%22Cheng+AL%22">Cheng AL</searchLink>; National Taiwan University College of Medicine, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22El-Khoueiry+AB%22">El-Khoueiry AB</searchLink>; USC Norris Comprehensive Cancer Center, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Abou-Alfa+GK%22">Abou-Alfa GK</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Weill Medical College at Cornell University, New York, New York, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101597993%22">Liver cancer</searchLink> [Liver Cancer] 2021 Dec 03; Vol. 11 (1), pp. 38-47. <i>Date of Electronic Publication: </i>2021 Dec 03 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22S%2E+Karger%22">S. Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101597993 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2235-1795 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216645553%22">16645553 </searchLink><i>NLM ISO Abbreviation: </i>Liver Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35222506
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1159/000519867
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 38
    Titles:
      – TitleFull: Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rimassa L
      – PersonEntity:
          Name:
            NameFull: Kelley RK
      – PersonEntity:
          Name:
            NameFull: Meyer T
      – PersonEntity:
          Name:
            NameFull: Ryoo BY
      – PersonEntity:
          Name:
            NameFull: Merle P
      – PersonEntity:
          Name:
            NameFull: Park JW
      – PersonEntity:
          Name:
            NameFull: Blanc JF
      – PersonEntity:
          Name:
            NameFull: Lim HY
      – PersonEntity:
          Name:
            NameFull: Tran A
      – PersonEntity:
          Name:
            NameFull: Chan YW
      – PersonEntity:
          Name:
            NameFull: McAdam P
      – PersonEntity:
          Name:
            NameFull: Wang E
      – PersonEntity:
          Name:
            NameFull: Cheng AL
      – PersonEntity:
          Name:
            NameFull: El-Khoueiry AB
      – PersonEntity:
          Name:
            NameFull: Abou-Alfa GK
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 12
              Text: 2021 Dec 03
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2235-1795
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Liver cancer
              Type: main
ResultId 1